Carl Zeiss Meditec AG (AFX:XETRA) Annual Income Statement (EUR)
AFX:XETRA Quarterly Financials (EUR)
Frequently Asked Questions About Carl Zeiss Meditec AG (AFX:XETRA) Stock
Carl Zeiss Meditec AG's (AFX:XETRA) last reported annual revenue was N/A.
Carl Zeiss Meditec AG's (AFX:XETRA) annual revenue growth rate based on the revenue reported in the past 5 years is : 10.28%
Carl Zeiss Meditec AG's(AFX:XETRA) is not profitable as of its last reported annual financials.
The net profit margin for Carl Zeiss Meditec AG's(AFX:XETRA) from its laster reported year is N/A
The return on equity (ROE) for Carl Zeiss Meditec AG's(AFX:XETRA) from its last reported annual financials is : 12.83%
The return on assets (ROA) for Carl Zeiss Meditec AG's(AFX:XETRA) from its last reported annual financials is : 7.03%
The return on invested capital (ROIC) for Carl Zeiss Meditec AG's(AFX:XETRA) from its last reported annual financials is : 9.68%
The Debt to Equity ratio for Carl Zeiss Meditec AG's(AFX:XETRA) from its last reported annual financials is : 0.00%
The dividend yield for Carl Zeiss Meditec AG's(AFX:XETRA) from its laster reported year is 1.95%
Carl Zeiss Meditec AG's(AFX:XETRA) has negative cash flow as of its last reported annual financials.
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Underpriced compared to book value
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
High Gross Profit to Asset Ratio
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
What not to like
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Below median total returns
The company has under performed its peers on annual average total returns in the past 5 years.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for AFX:XETRA !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
